NCT04875871 2025-05-11
PARTICLE-PATHY
EBG MedAustron GmbH
Phase NA Terminated
Clinical Trials
8 trialsNCT05133128 2024-02-22
IMMUNOPBMC
Servier
Phase NA Terminated
NCT03860207 2023-09-13
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
Y-mAbs Therapeutics
Phase 1/2 Terminated
NCT05437679 2023-09-05
CHARTER
Angle plc
Terminated
NCT03371420 2023-04-18
PET Imaging of Subjects Using 124I-PU-AD
Samus Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT04264754 2021-05-06
Characterization of Methylation Patterns in Hepatocellular Carcinoma
Nucleix Ltd.
Terminated
NCT00685750 2019-06-20
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
GlaxoSmithKline
Phase NA Terminated
NCT01521780 2015-11-02
Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)
Merck Sharp & Dohme LLC
Phase 1 Terminated